Jiao Wu
Impact in
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Cancer-related molecular mechanisms research 12
- Cancer, Lipids, and Metabolism 7
- MicroRNA in disease regulation 5
-
- Signaling Pathways in Disease 12
- Circular RNAs in diseases 8
- RNA modifications and cancer 6
- Co-authors
- Xuejun JiangZhi‐Nan ChenHuijie BianJun-Mei YiCraig B. ThompsonJiajun ZhuYong LiMinghui Gao
- Journals
- Nature Communications (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Comprehensive physiology (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jiao Wu
88 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.7k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 2.6k
- Immunology 470
- Oncology 541
Countries citing papers authored by Jiao Wu
This map shows the geographic impact of Jiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiao Wu more than expected).
Fields of papers citing papers by Jiao Wu
This network shows the impact of papers produced by Jiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiao Wu. The network helps show where Jiao Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1/TLR4/STAT3 axis in M1 macrophages Hit paper breakdown → | 2024 | 55 |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 38 | |
| 11 | 2022 | 0 | |
| 12 | 2021 | 45 | |
| 13 | 2021 | 14 | |
| 14 | Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer Hit paper breakdown → | 2021 | 256 |
| 15 | Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis Hit paper breakdown → | 2020 | 688 |
| 16 | Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling Hit paper breakdown → | 2019 | 824 |
| 17 | 2014 | 48 | |
| 18 | Research progress on Hierodula patellifera Serville. | 2014 | 1 |
| 19 | 2013 | 23 | |
| 20 | 2010 | 1 |
About Jiao Wu
Jiao Wu is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 98 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (12 papers), Cancer-related molecular mechanisms research (12 papers), Signaling Pathways in Disease (12 papers), Circular RNAs in diseases (8 papers), Cancer, Lipids, and Metabolism (7 papers), RNA modifications and cancer (6 papers), Diabetes Treatment and Management (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (1.7k citations), Pulmonary and Respiratory Medicine (1.9k citations), Molecular Biology (2.6k citations), Immunology (470 citations) and Oncology (541 citations). Jiao Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xuejun Jiang, Zhi‐Nan Chen, Huijie Bian, Jun-Mei Yi, Craig B. Thompson, Jiajun Zhu, Yong Li, Minghui Gao, Brent R. Stockwell and Alexander M. Minikes. Their work appears in journals such as Nature Communications, PLoS ONE, Scientific Reports, Comprehensive physiology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.